Back to results
US 2010/0063080 A1Published application
CXCR2 inhibitors
OwnerNeil John Press, Peter Hunt +2inventors
InventorsNeil John Press, Peter Hunt, David Porter, Diana Janus
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.
Claims11
A method for the prevention or treatment of a CXCR2 receptor mediated condition or disease comprising administering an effective amount of at least one compound of formula
- wherein
- R1 is (C6-18)aryl or (C6-18)aryl(C1-4)alkyl, unsubstituted or one- or morefold substituted by (C1-4)alkyl, C1-4)alkoxy, hydroxy, halogen,
- R2 is
- (C1-8)alkyl, halo(C1-8)alkyl, amino, substituted amino,
- (C6-18)aryl, unsubstituted or one- or morefold substituted by (C1-4)alkyl, C1-4)alkoxy, hydroxy or halogen,
- (C6-18)aryl(C1-8)alkyl, unsubstituted or one- or morefold substituted,
- heterocyclyl or heterocyclyl(C1-8)alkyl, wherein heterocyclyl has 5 to 6 ring members and 1 to 4 heteroatoms selected from N, O, S, unsubstituted or one- or morefold substituted,
- (C3-8)cycloalkyl or (C3-8)cycloalkyl(C1-8)alkyl, unsubstituted or, one- or morefold substituted,
- or a pharmaceutically acceptable salt or solvate thereof.
6 more elements
A compound selected from the group consisting of
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(4-methoxy-phenyl)-pyrimidine-5-carbonitrile,
- 4-(3,4-Dichlorophenyl)-2-(2,3-difluorobenzylsulfanyl-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluorobenzylsulfanyl)-4-hydroxy-6-(4-hydroxyphenyl)-pyrimidine-5-carbonitrile,
- 4-cyclopropyl-2-(2,3-difluorobenzylsulfanyl-6-hydroxypyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-phenyl-pyrimidine-5-carbonitrile,
- 4-(4-Chlorophenyl)-2-(2,3-difluoro-benzyl-sulfanyl)-6-hydroxy-6-phenyl-pyrimidine-5-carbonitrile,
- 4-(4-Methylphenyl)-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-6-phenyl-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-furan-2-yl-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-pyridin-3-yl-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-pyridin-4-yl-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(4-thiophen-2-yl-phenyl)-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-m-tolyl-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-furan-3-yl-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(4-isopropoxy-phenyl)-pyrimidine-5-carbonitrile,
- 4-(4-tert-Butyl-phenyl)-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-(3,4-dimethyl-phenyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 4-Cyclopentyl-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 4-Cyclopropyl-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(4-methoxy-3-methyl-phenyl)-pyrimidine-5-carbonitrile,
- 4-Cyclobutyl-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-isopropyl-pyrimidine-5-carbonitrile,
- 4-Cyclohexyl-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropanecarboxylic acid ethyl ester,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-ethyl-6-hydroxy-pyrimidine-5-carbonitrile,
- 4-sec-Butyl-2-(2,3-difluoro benzyl sulfanyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 4-tert-Butyl-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(1-phenyl-ethyl)-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-trifluoromethyl-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-methyl-pyrimidine-5-carbonitrile,
- 4-sec-Butyl-2-(2,3-difluoro-benzyl sulfanyl)-6-hydroxy pyrimidine-5-carbonitrile single enantiomer E1,
- 4-sec-Butyl-2-(2,3-difluoro-benzyl sulfanyl)-6-hydroxy pyrimidine-5-carbonitrile single enantiomer E2,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(3-hydroxy-phenyl)-pyrimidine-5-carbonitrile-4-sec-Butyl-2-(2,3-difluoro-benzyl sulfanyl)-6-hydroxy pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(1-phenyl-ethyl)-pyrimidine-5-carbonitrile,
- 4-Cyclopropylmethyl-2-(2,3-difluoro-benzylsulfanyl)-6 hydroxy-pyrimidine-5-carbonitrile,
- Trans-2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6 hydroxy-pyrimidin-4-yl]cyclopropane carboxylic acid,
- (1R,2R)-2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6 hydroxy-pyrimidin-4-yl]cyclopropane carboxylic acid,
- (1R,2R)-2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6 hydroxy-pyrimidin-4-yl]cyclopropane carboxylic acid,
- Trans-2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(2-hydroxymethyl-cyclopropyl)-pyrimidine-5-carbonitrile,
- Trans-2-[5-Cyano-2-(2,3-difluoro-benzyl sulfanyl)-6-hydroxy-pyrimidin-4-yl]cyclopropane carboxylic acid ethyl-(2-methyl-allyl)-amide,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid ethyl-methyl-amide,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid cyclopropyl methyl-amide,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-[2-(2-ethyl-pyrrolidine-1carbonyl)-cyclopropyl]-6-hydroxypyrimidine-5-carbonitrile,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid (1-methoxymethyl-propyl)-amide,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid phenethyl-amide,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid 2-methoxy-benzylamide,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-[2-(3-hydroxy-piperidine-1-carbonyl)cyclopropyl]-pyrimidine-5-carbonitrile,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid (pyridin-3-ylmethyl)-amide,
- Trans-({2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carbonyl}-amino)-acetic acid ethyl ester,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-[2-(morpholine-4-carbonyl)-cyclopropyl]pyrimidine-5-carbonitrile,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid (furan-2-ylmethyl)-amide,
- 2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carboxylic acid amide,
- Trans-4-{2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carbonyl}-piperazine-1-carboxylic acid tert-butyl ester,
- Trans-({2-[5-Cyano-2-(2,3-difluoro-benzylsulfanyl)-6-hydroxy-pyrimidin-4-yl]-cyclopropane carbonyl}-amino)-acetic acid,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-[(R)-2-(5-methyl-furan-2-yl)-propyl]-pyrimidine-5-carbonitrile,
- (1S,2S)-2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(2-hydroxymethyl-cyclopropyl)-pyrimidine-5-carbonitrile,
- 2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-[(R)-1-(5-methyl-furan-2-yl)-propylamino]-pyrimidine-5-carbonitrile and
- (1R,2R)-2-(2,3-Difluoro-benzylsulfanyl)-4-hydroxy-6-(2-hydroxymethyl-cyclopropyl)-pyrimidine-5-carbonitrile.
54 more elements
(canceled)
Dependencies are inferred from the claim text.